+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Bayer AG (BAYN) - Financial and Strategic SWOT Analysis Review

  • ID: 1292013
  • SWOT Analysis
  • 77 pages
  • GlobalData
  • Bayer AG
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 4

FEATURED COMPANIES

  • Allergan Plc
  • DowDuPont Inc
  • GlaxoSmithKline Plc
  • Huntsman Corp
  • Mitsubishi Chemical Corp
  • Pfizer Inc
  • MORE
Bayer AG (BAYN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

Critical Information Included
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Bayer AG (Bayer) carries out the research, development, production and commercialization of products for human and animal health care, and agriculture. It provides medicines for cardiovascular diseases, women’s health, cancer, hematology, ophthalmology and other indications. The company's product portfolio includes prescription products, specialty therapeutics, animal health care products, diagnostic imaging equipment, nonprescription (over-the-counter - OTC) products, seeds, crop protection solutions and nonagricultural pest control solutions. Bayer markets its healthcare and crop protection products essentially through wholesalers, pharmacies, hospitals and retailers. It operates through a network of subsidiaries in Asia-Pacific, Europe, North America, Latin America, Africa and the Middle East. Bayer is headquartered in Leverkusen, Germany.

Bayer AG Key Recent Developments

Mar 17, 2019 Bayer statement on new 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease
Mar 08, 2019 Bayer files for darolutamide marketing approval in Japan
Mar 08, 2019 Orion and Bayer Submit Marketing Authorization Application to EMA for Darolutamide
Mar 05, 2019 Bayer files prostate cancer drug darolutamide in Japan

Key Benefits

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Allergan Plc
  • DowDuPont Inc
  • GlaxoSmithKline Plc
  • Huntsman Corp
  • Mitsubishi Chemical Corp
  • Pfizer Inc
  • MORE
Section 1 - About the Company
  • Bayer AG - Key Facts
  • Bayer AG - Key Employees
  • Bayer AG - Key Employee Biographies
  • Bayer AG - Major Products and Services
  • Bayer AG - History
  • Bayer AG - Company Statement
  • Bayer AG - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
  • Joint Venture
Section 2 – Company Analysis
  • Company Overview
  • Bayer AG - Business Description
  • Business Segment: All Other Segments
  • Overview
  • Performance
  • Business Segment: Animal Health
  • Overview
  • Performance
  • Key Stats
  • Business Segment: Consumer Health
  • Overview
  • Performance
  • Key Stats
  • Business Segment: Crop Science
  • Overview
  • Performance
  • Key Stats
  • Business Segment: Pharmaceuticals
  • Overview
  • Performance
  • Key Stats
  • Geographical Segment: Asia Pacific
  • Performance
  • Geographical Segment: Europe, Middle East and Africa
  • Performance
  • Geographical Segment: Latin America
  • Performance
  • Geographical Segment: North America
  • Performance
  • R&D Overview
  • Bayer AG - Corporate Strategy
  • Bayer AG - SWOT Analysis
  • SWOT Analysis - Overview
  • Bayer AG - Strengths
  • Bayer AG - Weaknesses
  • Bayer AG - Opportunities
  • Bayer AG - Threats
  • Bayer AG - Key Competitors
Section 3 – Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
  • Bayer AG, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
  • Bayer AG, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
  • Bayer AG, Recent Deals Summary
Section 5 – Company’s Recent Developments
  • Mar 17, 2019: Bayer statement on new 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease
  • Mar 08, 2019: Bayer files for darolutamide marketing approval in Japan
  • Mar 08, 2019: Orion and Bayer Submit Marketing Authorization Application to EMA for Darolutamide
  • Mar 05, 2019: Bayer files prostate cancer drug darolutamide in Japan
  • Feb 27, 2019: Bayer completes rolling submission for darolutamide in U.S.
  • Feb 27, 2019: Bayer increases sales and earnings – leader in agriculture after acquisition
  • Feb 15, 2019: Bayer gains full rights to TRK inhibitors Vitrakvi, LOXO-195 as Eli Lilly completes Loxo Oncology deal
  • Feb 15, 2019: Bayer Bags Full Vitrakvi Rights As Lilly Signs Off Loxo Buy
  • Feb 15, 2019: Bayer antes up on Vitrakvi just as Roche rival wins fast review
  • Feb 13, 2019: Bayer donates $130,000 to 13 domestic violence shelters through new Grants Fur Families program
Section 6 – Appendix
  • Methodology
  • Ratio Definitions
  • About the Author
  • Contact Us
  • Disclaimer
List of Tables
  • Bayer AG, Key Facts
  • Bayer AG, Key Employees
  • Bayer AG, Key Employee Biographies
  • Bayer AG, Major Products and Services
  • Bayer AG, History
  • Bayer AG, Subsidiaries
  • Bayer AG, Joint Venture
  • Bayer AG, Key Competitors
  • Bayer AG, Ratios based on current share price
  • Bayer AG, Annual Ratios
  • Bayer AG, Annual Ratios (Cont...1)
  • Bayer AG, Annual Ratios (Cont...2)
  • Bayer AG, Interim Ratios
  • Bayer AG, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
  • Bayer AG, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
  • Bayer AG, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Bayer AG, Performance Chart (2014 - 2018)
  • Bayer AG, Ratio Charts
  • Bayer AG, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
  • Bayer AG, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Zoetis Inc
  • Virbac Group
  • Pfizer Inc
  • Novartis AG
  • Mitsubishi Chemical Corp
  • Johnson & Johnson
  • Huntsman Corp
  • Heska Corp
  • GlaxoSmithKline Plc
  • F. Hoffmann-La Roche Ltd
  • Edgewell Personal Care LLC
  • DowDuPont Inc
  • BASF SE
  • Allergan Plc
Note: Product cover images may vary from those shown
Adroll
adroll